找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Biopharmaceutics Applications in Drug Development; Rajesh Krishna,Lawrence Yu Book 2008 Springer-Verlag US 2008 absorption.bioequivalence.

[復(fù)制鏈接]
樓主: Colossal
11#
發(fā)表于 2025-3-23 10:10:17 | 只看該作者
Christian Werner,Volker Klein,Konradin Weberds has become one of the most important tests in drug product development and manufacturing, as well as in regulatory assessment of drug product quality. Not only can dissolution testing provide information regarding the rate and extent of drug absorption in the body, it can also assess the effects
12#
發(fā)表于 2025-3-23 16:30:40 | 只看該作者
13#
發(fā)表于 2025-3-23 20:21:22 | 只看該作者
14#
發(fā)表于 2025-3-23 23:29:22 | 只看該作者
H. J. K?lsch,P. Rairoux,J. P. Wolf,L. W?steliver the drug at the right place at the right time and with the right dose with the optimal delivery characteristics. Basically, an excipient has to fulfill the same safety profile as a drug with the exception that it should not exert a therapeutic effect. Most excipients do comply with these requi
15#
發(fā)表于 2025-3-24 03:53:05 | 只看該作者
Herbert Schneckenburger,Werner Schmidtinitial stages of drug discovery, numerous studies are performed to assess the pharmacological effectiveness of new chemical entities (NCEs) to select a lead compound(s) that offers the greatest promise for therapeutic efficacy. While the ability of a drug to bind to a therapeutic target is critical
16#
發(fā)表于 2025-3-24 09:18:14 | 只看該作者
R. Bombach,B. Hemmerling,W. Kreutnerug absorption have been discussed in previous chapters. This chapter will cover general methods to evaluate bioavailability and bioequivalence. Scientific principles as well as regulatory perspectives related to these two topics will be discussed. Historically, the development of sensitive and preci
17#
發(fā)表于 2025-3-24 13:51:31 | 只看該作者
https://doi.org/10.1007/978-3-662-08252-2is a required performance test by many regulatory authorities for solid oral dosage forms, transdermal patches, stents, and oral suspensions. Dissolution testing is unique in that it is the only finished product test method in routine use that measures the effect of the formulation and physical prop
18#
發(fā)表于 2025-3-24 17:18:33 | 只看該作者
19#
發(fā)表于 2025-3-24 22:50:33 | 只看該作者
H. G. Dahn,W. Lüdeker,K. P. Güntherssolution. Biological properties such as .max, or AUC have been used to correlate with . dissolution behavior such as percent drug release in order to establish IVIVC. IVIVC can be used to set product dissolution specifications; and as a surrogate for . bioequivalence in the case of any changes with
20#
發(fā)表于 2025-3-25 01:23:30 | 只看該作者
B. Fuchs,H.-P. Berlien,G. Müller,W. Gorischrally administered drug products, it is usually a correlation between the extent or rate of dissolution of a dosage form and its pharmacokinetic parameters, such as rate, duration, and extent of drug absorption. The physicochemical properties of dosage forms influence their . performance in many dif
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 19:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
嘉义市| 个旧市| 汾阳市| 纳雍县| 绥芬河市| 安顺市| 临江市| 永康市| 正安县| 红河县| 洛阳市| 柳江县| 那曲县| 马山县| 阿拉善左旗| 呼和浩特市| 岫岩| 乌兰县| 清水县| 城口县| 辽阳市| 平利县| 武宁县| 南投县| 廉江市| 石门县| 卢湾区| 大悟县| 高雄县| 长丰县| 凤庆县| 明水县| 修武县| 丰台区| 永春县| 卫辉市| 沐川县| 蒲江县| 安化县| 荔浦县| 凯里市|